TRIPTIMMUNE Trademark

Trademark Overview


On Wednesday, October 25, 2017, a trademark application was filed for TRIPTIMMUNE with the United States Patent and Trademark Office. The USPTO has given the TRIPTIMMUNE trademark a serial number of 79225650. The federal status of this trademark filing is REGISTERED as of Tuesday, November 6, 2018. This trademark is owned by Debiopharm International SA. The TRIPTIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of prostate cancer, melanoma, lung cancer, kidney cancer, bladder cancer, ovarian cancer, head and neck cancer, gastric cancer, colorectal cancer, breast cancer, mesothelioma, Hodgkin's lymphoma
triptimmune

General Information


Serial Number79225650
Word MarkTRIPTIMMUNE
Filing DateWednesday, October 25, 2017
Status700 - REGISTERED
Status DateTuesday, November 6, 2018
Registration Number5598121
Registration DateTuesday, November 6, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of prostate cancer, melanoma, lung cancer, kidney cancer, bladder cancer, ovarian cancer, head and neck cancer, gastric cancer, colorectal cancer, breast cancer, mesothelioma, Hodgkin's lymphoma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDebiopharm International SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameDebiopharm International SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameDebiopharm International SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, November 6, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, March 1, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 9, 2019FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 9, 2019FINAL DISPOSITION PROCESSED
Wednesday, February 6, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Friday, August 17, 2018NOTIFICATION PROCESSED BY IB
Wednesday, August 1, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 1, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, July 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 4, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 2, 2018REFUSAL PROCESSED BY IB
Wednesday, February 14, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 14, 2018REFUSAL PROCESSED BY MPU
Friday, February 9, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 9, 2018APPLICATION FILING RECEIPT MAILED
Thursday, February 8, 2018NON-FINAL ACTION WRITTEN
Monday, February 5, 2018ASSIGNED TO EXAMINER
Monday, February 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 1, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB